Stocks Hitting 52-Week Lows
October 06, 2014 at 10:20 AM EDT
Sunesis Pharmaceuticals (NASDAQ: SNSS) shares tumbled 69.88% to reach a new 52-week low of $2.00 as pivotal Phase 3 VALOR trial of acute ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.